The HemOnc Pulse cover image

The ABCs of MM Treatment According to Rafael Fonseca, MD

The HemOnc Pulse

CHAPTER

Bi-specific Therapies for Multiple Myeloma

A discussion on bi-specific therapies for multiple myeloma, including the FDA-approved Clistamab and upcoming Elranathamab. The chapter explores their effectiveness in controlling cancer cells and the concern over infections due to their effects on the immune system.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner